Episode 136 -- Frontiers of Treatment with Dr. Thomas Cabell and Chad Harman

Research has rekindled interest in the therapeutic power of psychedelics in the clinical treatment of anxiety, depression, and addiction.  Dr. Thomas Cabel and Chad Harman, CEO of Psycheseuticals, explore the status of the field in this revealing interview.